Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the long-term efficacy, local tolerability and safety of
Lisuride applied as subcutaneous infusion compared to placebo in patients with advanced
Parkinson's disease with motor fluctuations and "OFF" periods refractory to conventional
treatment.